Compare NATH & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NATH | SLP |
|---|---|---|
| Founded | 1916 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | EDP Services |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.6M | 322.4M |
| IPO Year | N/A | 1997 |
| Metric | NATH | SLP |
|---|---|---|
| Price | $95.22 | $19.18 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $26.80 |
| AVG Volume (30 Days) | 50.8K | ★ 434.1K |
| Earning Date | 11-06-2025 | 01-06-2026 |
| Dividend Yield | ★ 2.10% | N/A |
| EPS Growth | ★ 4.02 | N/A |
| EPS | ★ 5.56 | N/A |
| Revenue | ★ $154,991,000.00 | $79,179,000.00 |
| Revenue This Year | N/A | $2.02 |
| Revenue Next Year | N/A | $6.92 |
| P/E Ratio | $17.13 | ★ N/A |
| Revenue Growth | 7.82 | ★ 13.09 |
| 52 Week Low | $75.15 | $12.39 |
| 52 Week High | $118.50 | $37.67 |
| Indicator | NATH | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 47.62 | 58.86 |
| Support Level | $88.67 | $19.20 |
| Resistance Level | $97.34 | $20.06 |
| Average True Range (ATR) | 3.30 | 0.88 |
| MACD | 0.76 | 0.08 |
| Stochastic Oscillator | 71.64 | 61.66 |
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.